Qatar University (QU)’s Ibn Khaldon for Humanities and Social Studies Centre, in co-operation with the Ministry of Endowments ...
A "groundbreaking" new technology developed by Heriot-Watt University in Edinburgh, poised to "revolutionise" the diagnosis ...
'The scale of ambition I have for York is unparalleled today' - Rachael Maskell MP ...
Some of the tips job seekers may have heard in the past no longer reflect how hiring decisions are made—and following ...
Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson’s Disease and Movement Disorders® 2025· Details of the Phase 3 ...
A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.
In the mid- to late 20th century, the World Bank championed large dam projects as engines of economic growth. The bank ...
Madeline Lancaster created the first brain organoids, which have revolutionised our understanding of how the brain works - ...
At the time of writing, GBP/USD is trading around 1.3520, extending its winning streak for a fourth day with a gain of over 0 ...
The Punch on MSN
WAICA Conference: W’African insurers tackle climate risks
The West African Insurance Companies Association Education Conference is set to open in Lagos this October with a focus on ...
New findings reveal zongertinib's effectiveness against brain metastases in HER2-mutant non–small cell lung cancer, offering hope for better treatment options. Human epidermal growth factor receptor 2 ...
Cancer. Diabetes. Aging itself. Rapamycin’s potential to treat an array of diseases has been a source of scientific fascination. But many aren’t aware of its origins – and its complicated legacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results